These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2083207)
41. Clinical significance of insulin antibodies in insulin-treated diabetic patients. Van Haeften TW Diabetes Care; 1989 Oct; 12(9):641-8. PubMed ID: 2676431 [TBL] [Abstract][Full Text] [Related]
42. Glucagon antibodies after long-term insulin treatment in a diabetic child. Stahl M; Nars PW; Herz G; Baumann JB; Girard J Horm Metab Res; 1972 May; 4(3):224-5. PubMed ID: 5065152 [No Abstract] [Full Text] [Related]
43. [Role of immunological factors in the pathogenesis of insulin dependent diabetes mellitus]. Pozza G; Cattaneo R; Saibene V; Balestrieri G Journ Annu Diabetol Hotel Dieu; 1979; ():221-32. PubMed ID: 502128 [No Abstract] [Full Text] [Related]
44. [Use of human insulin preparations in the treatment of patients with insulin-dependent diabetes mellitus]. Perelygina AA; Smirnova OM; Lobanova AM; Gorelysheva VA Probl Endokrinol (Mosk); 1988; 34(1):3-5. PubMed ID: 3283725 [TBL] [Abstract][Full Text] [Related]
45. Serum antibody-bound insulin as a measure of insulin antibodies in diabetic children. Koskinen P; Kaihola HL; Mäkelä AL; Irjala K; Knip M; Akerblom HK Diabetes Res; 1987 Sep; 6(1):15-9. PubMed ID: 3319351 [TBL] [Abstract][Full Text] [Related]
46. Successful treatment of unusual case of brittle diabetes with sulfated beef insulin. Davidson MB; Kumar D; Smith W Diabetes Care; 1991 Nov; 14(11):1109-10. PubMed ID: 1797500 [No Abstract] [Full Text] [Related]
48. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients. Sakata S; Matsuda M; Komaki T; Miura K Immunol Invest; 1986 Dec; 15(8):791-9. PubMed ID: 3298026 [TBL] [Abstract][Full Text] [Related]
49. [Anti-insulin antibodies and their development in relation to therapy]. Synek M Cesk Pediatr; 1987 Oct; 42(10):614-6. PubMed ID: 3322582 [No Abstract] [Full Text] [Related]
50. [Comparison of semisynthetic human insulin and porcine insulin in diabetic patients with or without circulating anti-insulin antibodies]. Vandeleene B; Ketelslegers JM; Lambert AE Acta Clin Belg; 1983; 38(6):360-8. PubMed ID: 6369853 [No Abstract] [Full Text] [Related]
51. [Specific immunologic resistance to bovine insulin in an insulin-dependent diabetic]. Vialettes B; Moulin JP; Gillet T; Bourrely N; Vague P Presse Med; 1984 Jun; 13(27):1675-7. PubMed ID: 6234574 [TBL] [Abstract][Full Text] [Related]
52. Deleterious effect of anti-insulin antibodies on diabetes control. Livneh A; Avraham H; Bistritzer T; Weisglass L; Theodor R; Sack J Isr J Med Sci; 1990 Jan; 26(1):11-5. PubMed ID: 2179155 [TBL] [Abstract][Full Text] [Related]
53. The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin. Heding LG; Larsson Y; Ludvigsson J Diabetologia; 1980; 19(6):511-5. PubMed ID: 7007131 [No Abstract] [Full Text] [Related]
54. The effect of insulin antibodies on insulin dose and diabetic control. Walford S; Allison SP; Reeves WG Diabetologia; 1982 Feb; 22(2):106-10. PubMed ID: 7037511 [TBL] [Abstract][Full Text] [Related]
55. Endogenous plasma insulin in a juvenile diabetic after ten years of insulin therapy. Johansen K Arch Intern Med; 1971 Jan; 127(1):139-40. PubMed ID: 5538984 [No Abstract] [Full Text] [Related]
56. Immunogenicity of semisynthetic human insulin. Rogala H; Lawecki J; Czyzyk A Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505 [No Abstract] [Full Text] [Related]
57. Insulin antibodies in diabetics after changeover from conventional NPH to highly purified insulin. Chandraprasert S; Bunnag SC Ann Acad Med Singap; 1985 Apr; 14(2):289-93. PubMed ID: 3898980 [TBL] [Abstract][Full Text] [Related]
58. Insulin antibodies in 104 children with diabetes mellitus. Nars PW; Herz G; Girard J Eur J Pediatr; 1976 Jun; 122(3):217-22. PubMed ID: 1278189 [TBL] [Abstract][Full Text] [Related]
59. Insulin-binding antibodies in serum of diabetic children treated with monocomponent insulin. Symonides-Lawecka A; Ludwiczak H; Rogala H; Lawecki J; Czyzyk A Acta Diabetol Lat; 1974; 11(2):165-70. PubMed ID: 4432728 [No Abstract] [Full Text] [Related]
60. Disappearance rate of insulin antibodies after discontinuing insulin treatment in 42 type 2 (non-insulin-dependent) diabetic patients. Ionescu-Tîrgovişte C; Mincu I; Simionescu L; Cheţa D; Mirodon Z; Sântu E; Popa E; Bîrnea A Diabetologia; 1984 Dec; 27(6):592-5. PubMed ID: 6397385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]